NasdaqCM - Delayed Quote USD

Medicus Pharma Ltd. (MDCX)

2.5500
-1.0850
(-29.85%)
At close: May 30 at 4:00:02 PM EDT
2.5300
-0.02
(-0.78%)
After hours: May 30 at 7:32:56 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
14,599.8180
11,180.9020
2,658.3650
978.4160
1,441.3880
Operating Income
-14,599.8180
-11,180.9020
-2,658.3650
-978.4160
-1,441.3880
Net Non Operating Interest Income Expense
-189.2650
-213.1310
-584.8200
-1,102.2720
-690.8530
Other Income Expense
--
238.5170
-2,071.5800
388.3060
76.9780
Pretax Income
-14,550.5660
-11,155.5160
-5,314.7650
-1,692.3820
-2,055.2630
Net Income Common Stockholders
-14,550.5660
-11,155.5160
-5,314.7650
-1,692.3820
-2,055.2630
Diluted NI Available to Com Stockholders
-14,550.5660
-11,155.5160
-5,314.7650
-1,692.3820
-2,055.2630
Basic EPS
-1.37
-1.16
-1.53
-0.88
-0.26
Diluted EPS
-1.37
-1.16
-1.53
-0.88
-0.26
Basic Average Shares
10,660.1250
9,619.1840
3,479.4940
1,930.2610
8,048.8420
Diluted Average Shares
10,660.1250
9,619.1840
3,479.4940
8,048.8420
8,048.8420
Total Operating Income as Reported
-14,599.8180
-11,180.9020
-4,729.9450
-978.4160
-1,441.3880
Total Expenses
14,599.8180
11,180.9020
2,658.3650
978.4160
1,441.3880
Net Income from Continuing & Discontinued Operation
-14,550.5660
-11,155.5160
-5,314.7650
-1,692.3820
-2,055.2630
Normalized Income
-14,789.0830
-11,394.0330
-3,243.1850
-2,080.6880
-2,132.2410
Interest Income
128.2770
104.4110
--
--
--
Interest Expense
--
902.3620
739.0960
526.8250
115.4060
Net Interest Income
-189.2650
-213.1310
-584.8200
-1,102.2720
-690.8530
EBIT
-13,672.0700
-10,253.1540
-2,658.3650
-1,165.5570
-1,939.8570
EBITDA
-13,672.0700
-10,253.1540
-2,658.3650
-1,165.5570
-1,939.8570
Net Income from Continuing Operation Net Minority Interest
-14,550.5660
-11,155.5160
-5,314.7650
-1,692.3820
-2,055.2630
Total Unusual Items Excluding Goodwill
238.5170
238.5170
-2,071.5800
388.3060
76.9780
Total Unusual Items
238.5170
238.5170
-2,071.5800
388.3060
76.9780
Normalized EBITDA
-13,910.5870
-10,491.6710
-586.7850
-1,553.8630
-2,016.8350
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/14/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SCLX Scilex Holding Company
5.12
-9.38%
 
SNY Sanofi
49.37
-5.69%
 
AZN AstraZeneca PLC
72.83
+2.77%
 
AMRN Amarin Corporation plc
11.59
-0.77%
 
AMGN Amgen Inc.
288.18
+1.64%
 
OGN Organon & Co.
9.22
-3.35%
 
NVS Novartis AG
115.76
+2.82%
 
NONOF Novo Nordisk A/S
70.98
+2.57%
 
MRK Merck & Co., Inc.
76.84
+0.58%
 
BMY Bristol-Myers Squibb Company
48.28
+0.90%